
1. General Information
OCTRIDE DEPOT 30 mg contains octreotide, a somatostatin analogue that reduces the release of several hormones, particularly growth hormone, glucagon and insulin. The depot formulation is designed to release the medicine gradually over an extended period, reducing the need for frequent injections.
It is a prescription medicine and should be used under the supervision of a qualified healthcare professional.
For international supply, Phoenix Exim can present the product as a pharmaceutical export offering from Nagpur, India, subject to applicable regulatory, import and prescription requirements in the destination country.
2. Product Information
- Product: OCTRIDE DEPOT 30 mg Injection
- Active ingredient: Octreotide
- Strength: 30 mg
- Dosage form: Long-acting depot injectable suspension
- Therapeutic class: Somatostatin analogue
- Route: Intramuscular depot injection, when using an octreotide LAR formulation
- Administration: Generally administered by a healthcare professional
- Storage: Follow the manufacturer's packaging and product-specific storage instructions.
- Packaging: May vary according to the manufacturer.
For comparison, the FDA-approved Sandostatin LAR Depot 30 mg contains octreotide acetate equivalent to 30 mg octreotide in biodegradable microspheres and is administered as a gluteal intramuscular injection.
3. Uses of This Medicine
Long-acting octreotide is used under specialist supervision for:
Acromegaly
It helps reduce excessive growth hormone (GH) and IGF-1 levels in patients with acromegaly when appropriate treatment is required.
Neuroendocrine/carcinoid tumors
Octreotide can help control symptoms such as severe diarrhea and flushing associated with metastatic carcinoid tumors.
VIP-secreting tumors
It may be used for controlling profuse watery diarrhea associated with vasoactive intestinal peptide (VIP)-secreting tumors.
The exact indication depends on the country's approved labeling and the treating physician's assessment.
4. Benefits of This Medicine
Potential benefits of long-acting octreotide include:
- Helps control excessive hormone secretion.
- Can reduce growth hormone and IGF-1 levels in suitable patients with acromegaly.
- Helps control hormone-related symptoms associated with certain neuroendocrine tumors.
- Can reduce severe diarrhea and flushing associated with carcinoid syndrome.
- May help control watery diarrhea associated with VIPomas.
- The depot formulation provides prolonged drug release, which can reduce the frequency of administration compared with short-acting octreotide.
5. Side Effects of This Medicine
Octreotide can cause side effects, although not every patient experiences them.
Important potential adverse effects include:
- Gallbladder abnormalities and gallstones
- Changes in blood glucose, including hypoglycemia or hyperglycemia
- Changes in thyroid function
- Slow heart rate or other cardiac rhythm/conduction abnormalities
- Gastrointestinal disturbances
- Abdominal discomfort
- Injection-site reactions
- Changes in absorption of dietary fats and, with prolonged treatment, possible nutritional deficiencies
The FDA prescribing information specifically recommends monitoring for gallbladder complications, glucose abnormalities, thyroid function and cardiac effects.
6. Common Side Effects
Possible commonly reported effects include:
- Diarrhea
- Abdominal pain or discomfort
- Nausea
- Flatulence
- Constipation
- Headache
- Injection-site discomfort
- Gallstones or other gallbladder abnormalities
The frequency and severity can vary between patients and formulations.
Seek prompt medical attention for severe abdominal pain, symptoms suggestive of gallbladder complications, significant changes in blood sugar, fainting, or unusual heart-rate/rhythm symptoms.
7. How to Use
OCTRIDE DEPOT 30 mg should be administered by a trained healthcare professional according to the prescribing information.
For octreotide LAR formulations, the medicine is prepared as a suspension and administered by intramuscular injection into the gluteal region. The approved long-acting formulation is generally given at intervals of approximately 4 weeks, but the exact regimen depends on the indication and individual patient response.
Do not self-inject or change the dose/frequency without medical advice.
8. How This Medicine Works
Octreotide acts similarly to the natural hormone somatostatin.
It suppresses the release of several hormones, including:
- Growth hormone
- Glucagon
- Insulin
It also influences the release of various gastrointestinal and pancreatic hormones. By reducing excessive hormone secretion, octreotide can help control symptoms and biochemical abnormalities associated with acromegaly and certain hormone-secreting tumors.
The depot formulation uses biodegradable microspheres that gradually release octreotide after injection, providing prolonged exposure to the medicine.
9. Safety Advice
- Use only on the advice of a qualified healthcare professional.
- Inform the doctor about diabetes or blood-sugar problems because octreotide can cause either high or low blood glucose.
- Tell the doctor about previous or existing gallbladder problems.
- Patients receiving long-term therapy may require thyroid-function monitoring.
- Patients with heart disease or slow heart rate should inform their doctor before treatment.
- Tell the healthcare professional about all medicines being taken, including insulin, oral diabetes medicines, beta-blockers and other prescription medicines.
- Regular monitoring may be required during long-term treatment.
- Pregnancy and breastfeeding should be discussed with a healthcare professional before use.
- Do not use a damaged, improperly stored, expired or visibly compromised product.
- Follow the manufacturer's storage instructions because requirements may differ between formulations.
10. FAQs
Q1. What is OCTRIDE DEPOT 30 mg?
OCTRIDE DEPOT 30 mg is a long-acting injectable formulation containing octreotide, a somatostatin analogue used for controlling certain hormone-related conditions.
Q2. What is octreotide used for?
It is used for conditions including acromegaly and symptoms associated with certain neuroendocrine tumors, depending on the approved indication in the relevant country.
Q3. How often is octreotide depot given?
Many octreotide LAR formulations are administered approximately every 4 weeks, but the treatment schedule must be determined by the treating physician.
Q4. Can I administer OCTRIDE DEPOT myself?
Depot octreotide injections should generally be prepared and administered by a trained healthcare professional.
Q5. Does octreotide affect blood sugar?
Yes. It can cause either hypoglycemia or hyperglycemia, so blood glucose monitoring may be necessary.
Q6. Can octreotide cause gallstones?
Yes. Octreotide can reduce gallbladder contractility and may contribute to gallstones or other gallbladder complications.
Q7. Is OCTRIDE DEPOT 30 mg a prescription medicine?
Octreotide depot is a specialist prescription medicine and should be used under appropriate medical supervision.
Q8. Can the 30 mg strength be used for every patient?
No. The appropriate dose depends on the patient's condition, previous response to treatment, medical history and local prescribing information.
11. Substitute for This Medicine
Possible alternatives are other octreotide formulations or other somatostatin-receptor agonists, but they are not automatically interchangeable.
Examples may include:
- Octreotide immediate-release injection
- Other approved octreotide LAR/depot products
- Lanreotide depot formulations, where clinically appropriate
- Pasireotide in selected indications
The correct substitute depends on the diagnosis, indication, dose, formulation and country-specific approval. A physician or pharmacist should confirm the appropriate alternative rather than substituting products solely on the basis of strength. Octreotide LAR products also have specific administration requirements.
12. SEO / B2B Keywords
Primary Keywords:
- OCTRIDE DEPOT 30 mg Injection
- OCTRIDE DEPOT 30 mg exporter
- OCTRIDE DEPOT 30 mg supplier India
- Octreotide 30 mg injection
- Octreotide depot injection
- Octreotide 30 mg exporter India
- Octreotide depot supplier
- Octreotide LAR 30 mg
- Octreotide acetate 30 mg injection
- Octreotide injection manufacturer India
- Octreotide medicine supplier India
- Octreotide pharmaceutical exporter
- Octreotide depot injection supplier
- Octreotide 30 mg wholesale supplier
- Octreotide injection wholesale exporter
- Acromegaly medicine supplier
- Neuroendocrine tumor medicine supplier
- Somatostatin analogue supplier India
- OCTRIDE DEPOT pharmaceutical supplier
- OCTRIDE DEPOT medicine exporter from Nagpur
Country-focused B2B keywords:
- OCTRIDE DEPOT 30 mg exporter to USA
- OCTRIDE DEPOT 30 mg exporter to UK
- OCTRIDE DEPOT 30 mg exporter to Australia
- OCTRIDE DEPOT 30 mg exporter to Singapore
- OCTRIDE DEPOT 30 mg exporter to Canada
- OCTRIDE DEPOT 30 mg exporter to South Korea
- OCTRIDE DEPOT 30 mg exporter to UAE
- Octreotide 30 mg supplier from India
- Octreotide medicine exporter from Nagpur India
- Pharmaceutical exporter Nagpur India
- Octreotide injection international supplier
Keywords







